Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 Year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES)

European Heart Journal

Volumn 28, Issue 9, 2007, Pages 1128-1134

  Hobbs, F D Richard ^a   Roalfe, Andrea K ^a   Davis, Russell C ^a   Davies, Michael K ^b   Hare, Rachel ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SELLY OAK HOSPITAL   (United Kingdom)

Author keywords

Community; ECHOES; Heart failure; LVSD; Mortality; Prognosis

Indexed keywords

DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE SYSTOLIC DYSFUNCTION; HUMAN; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SCREENING; SURVIVAL; SURVIVAL RATE;

ADULT; AGED; CAUSE OF DEATH; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34548154261     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm102     Document Type: Article

References (27)

1. Davies MK, Hobbs FDR, Davis RC, Kenkre JE, Roalfe AK, Hare R, Wosornu D, Lancashire RJ. Prevalence of left ventricular systolic dysfunction and heart failure in the general population: main findings from the ECHOES (Echocardiographic Heart of England Screening) Study. Lancet 2001;358:439-445.
2. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ, Dargie HJ. Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population. Lancet 1997;350:29-33.
3. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993;22(4 Suppl. A):6A-13A.
4. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994;13(Suppl. 4):S107-S112.
5. Hobbs FDR, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 2002;23:1867-1876.
6. Garg R, Yusuf S for the Collaborative Group on ACE Inhibitor Trials. Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995;273:1450-1456.
7. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II. Lancet 1999;353:9-13.
8. Pitt B, Zannad F, Remm WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J for the Randomised Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-717.
9. Delahaye JP, Gare JP, Viguier E, Delahaye F, De Gevigney G, Milon H. Natural history of severe mitral regurgitation. Eur Heart J 1991;12:5-9.
10. Marantz PR, Tobin JN, Wassertheil-Smoller S, Steingart RM, Wexler JP, Budner N, Lense L, Wachspress J. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation 1988;77:607-612.
11. Clarke KW, Gray D, Hampton JR. How common is heart failure? Evidence from PACT (prescribing analysis and cost) data in Nottingham. J Pub Health Med 1995;17:459-464.
12. Hanumanthu S, Butler J, Chomsky D, Davis S, Wilson JR. Effect of a heart failure program on hospitalization frequency and exercise tolerance. Circulation 1997;96:2842-2848.
13. Rich WM, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-1195.
14. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
15. Cohn JG, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med 1986;314:1547-1552.
16. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.
17. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-533.
18. RALES Investigators. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). Am J Cardiol 1996;78:902-907.
19. Domanski MJ. Beta-Blocker Evaluation of Survival Trial (BEST). J Am Coll Cardiol 2000;35(Suppl. A):202A.
20. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study Subjects. Circulation 1993;88:107-115.
21. McDonagh TA, Cunningham AD, Morrison CE, McMurray JJ, Ford I, Morton JJ, Dargie HJ. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 2001;86:21-26.
22. Cleland JGF, Gemmell I, Khand A, Boddy A. Is the prognosis of heart failure improving? Eur J Heart Fail 1999;1:229-241.
23. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJV. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001;3:315-322.
24. Hewlett Packard Company. HP Acoustic Quantification user's guide PN77021-98160/1/2/4.
25. Norris RM, Barnaby PF, Brandt PW, Geary GG, Whitlock RM, Wild CJ, Barratt-Boyes BG. Prognosis after recovery from first myocardial infarction: determinants of reinfarction and sudden death. Am J Cardiol 1984;53:408-413.
26. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
27. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJV, Swedberg K, Ostergren J, Michelson EL, Pieper KS, Granger CB. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006;27:65-75.